Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

US9487535B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9487535-B2
Application numberUS-201313794147-A
CountryUS
Kind codeB2
Filing dateMar 11, 2013
Priority dateApr 12, 2012
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preparing a compound of formula (I): as an isolated (S)-enantiomer, or a non-racemic mixture of enantiomers having an enantiomeric excess of the (S)-enantiomer of greater than 80%, or a pharmaceutically acceptable salt thereof; wherein: p and r are each independently 1, 2, 3 or 4; R 1 is hydrogen, alkyl, alkenyl,…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9487535B2 cover?
This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Who is the assignee on this patent?
Xenon Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification C07D491/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).